|
|
|
|
|
by ippisl
5015 days ago
|
|
At the academic level , there seems to be a "space race". Maybe it could be improved by making the NIH invest in more radical high risk stuff. But the commercialization process sure sucks. Testing and verifying a drug is expensive, long and complex. But there seem to be some work going to improve that: 1. The FDA is becoming a bit more friendly[1].
2. There are some new innovations in how to run clinical trials. One example is [2].They claim they might bring drugs 1-3 years faster to market.
3. Organs on a chip are starting to become available and this might be more accurate than the mouse models used today. Since some of the new innovations in clinical trials do use web/mobile technology, i wonder what role startups can take in this area. [1]http://www.xconomy.com/national/2012/09/10/the-fda-turns-fri...
[2]http://disruptiveinnovationsinclinicaltrials.blogspot.co.il/... |
|